Additionally, KDM3B expression was found vital for the development of the aggressive phenotype in castration‐resistant prostate cancer [68]; it was associated with an increased proportion of cells with a stem cell phenotype, decreased apoptosis, and chemoresistance in colorectal cancer models [69]. Here, KDM3B is linked to prostate cancer.